Είστε εδώ

Τελευταία Νέα

Πηγή : medicalxpress.com

Distinct features for drug use-related endophthalmitis

(HealthDay)—Patients with injection drug use (IDU) endogenous endophthalmitis (EE) are younger, with fewer comorbidities, and have more improvement in visual acuity after intervention compared with non-IDU EE patients, according to a research letter published online Nov. 16 in JAMA Ophthalmology.

AMD risk has dropped by birth cohort throughout 20th century

(HealthDay)—There was a decrease in the five-year risk for age-related macular degeneration (AMD) by birth cohorts throughout the 20th century, according to a study published online Nov. 16 in JAMA Ophthalmology.

Research reveals biological mechanism of a leading cause of childhood blindness

Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.

Longer appointment times in clinic where trainees present

(HealthDay)—The presence of trainees in an outpatient ophthalmology clinic is associated with longer appointment times, even for appointments for which the trainee is not present, according to a study published online Nov. 9 in JAMA Ophthalmology.

Home remedies: Problems with pink eye

Pink eye (conjunctivitis) is an inflammation or infection of the transparent membrane (conjunctiva) that lines your eyelid and covers the white part of your eyeball. When small blood vessels in the conjunctiva become inflamed, they're more visible. This is what causes the whites of your eyes to appear reddish or pink.

Stem cell therapy shows promise for common cause of blindness

Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations given today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. Stem cells injected into the eye appear to have replaced the missing cells damaged by the disease, with no serious side effects. One study suggests it may have even improved patients' vision.

Hormone replacement therapy may protect against eye disease

Women who took estrogen-only hormone replacement therapy after ovary removal had a lower risk of developing glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

Wouldn't it be great if eyedrops didn't spill out of your eyes?

A new kind of eyedropper can deliver tiny droplets of medication, treating the eye more precisely than traditional eyedroppers, while reducing waste and avoiding dangerous side effects. According to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology, this technology may prove to be especially advantageous in the treatment of dry eye and glaucoma, for which patients require daily use of medicated eyedrops that can cost hundreds of dollars for a bottle that lasts only a month.

Another reason to exercise: Protecting your sight

People who engage in moderate to vigorous physical activity may be able to significantly lower their risk of glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. Researchers from the University of California, Los Angeles reported a 73 percent decline in the risk of developing the disease among the most physically active study participants, compared with those who were the least active.

Study finds racial disparities in gun-related eye trauma in the United States

A review of patients who suffered firearms-related eye trauma shows significant disparities in race, location, and circumstance, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. Most of the victims survive, but suffer traumatic brain injury and require extensive rehabilitation. The researchers say their study can inform the direction of future public policy.

Annoyed by floating specks in your vision? You may soon be able to zap them away

Millions of people who put up with seeing annoying specks drift through their field of vision may now have a safe, high-tech solution to their problem. A study of patients who had laser treatment to vaporize these flecks and spots known as floaters, showed a very low complication rate, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. Additionally, most patients reported a significant improvement in their vision.

Fish oil supplements and dry eyes

Dear Mayo Clinic: Is it true that fish oil or an omega-3 supplement can help people with dry eyes? If I decide to take them, do omega-3 supplements have any side effects I should worry about?

Soluble interleukin 2 receptor IDs sarcoidosis in uveitis

(HealthDay)—Soluble interleukin 2 receptor (sIL-2R) has slightly better diagnostic value than angiotensin-converting enzyme (ACE) for sarcoidosis in patients with uveitis, according to a study published online Nov. 9 in JAMA Ophthalmology.

At-home vision monitoring app may improve patient care

Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. The findings suggest that the smartphone app may help patients take better care of their vision.

Dry eye sufferers will soon have a drug-free solution

A study of dry eye sufferers who inserted a handheld neurostimulator device in their nose to make their eyes produce more tears experienced significant relief from their disease, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

Σελίδες

Προτεινόμενα Άρθρα